Effects of rosiglitazone treatment on serum amyloid-beta 1-40 and 1-42 in patients with early Alzheimer's disease

被引：2
|
作者：
Kulstad, J
Green, PS
Cook, DG
Watson, GS
Reger, M
Cholerton, B
Baker, LD
Plymate, SR
Asthana, S
Fishel, M
Kahn, SE
Craft, S
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] VA Med Ctr, Seattle, WA USA
[3] Univ Wisconsin, Madison, WI USA
[4] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)81167-9
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S354 / S355
页数：2
相关论文
共 50 条
  • [41] Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital
    Deltombe, Matthieu
    Fillee, Catherine
    van Pesch, Vincent
    ACTA NEUROLOGICA BELGICA, 2022, 122 (01) : 245 - 247
  • [42] Aggregation States of Aβ1-40, Aβ1-42 and Aβp3-42 Amyloid Beta Peptides: A SANS Study
    Festa, Giulia
    Mallamace, Francesco
    Sancesario, Giulia Maria
    Corsaro, Carmelo
    Mallamace, Domenico
    Fazio, Enza
    Arcidiacono, Laura
    Sakai, Victoria Garcia
    Senesi, Roberto
    Preziosi, Enrico
    Sancesario, Giuseppe
    Andreani, Carla
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
  • [43] Combination assay of CSF Tau, Aβ1-40 and Aβ1-42(43) as a biochemical marker of Alzheimer's disease
    Shoji, M
    Matsubara, E
    Kanai, M
    Watanabe, M
    Nakamura, T
    Tomidokoro, Y
    Shizuka, M
    Wakabayashi, K
    Igeta, Y
    Ikeda, Y
    Mizushima, K
    Amari, M
    Ishiguro, K
    Kawarabayashi, T
    Harigaya, Y
    Okamoto, K
    Hirai, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (02) : 134 - 140
  • [44] Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides
    Arispe, N
    Doh, M
    FASEB JOURNAL, 2002, 16 (12): : 1526 - 1536
  • [45] A beta 1-40 but not A beta 1-42 levels in cortex correlate with apolipoprotein E epsilon 4 allele dosage in sporadic Alzheimer's disease
    Ishii, K
    Tamaoka, A
    Mizusawa, H
    Shoji, S
    Ohtake, T
    Fraser, PE
    Takahashi, H
    Tsuji, S
    Gearing, M
    Mizutani, T
    Yamada, S
    Kato, M
    StGeorgeHyslop, PH
    Mirra, SS
    Mori, H
    BRAIN RESEARCH, 1997, 748 (1-2) : 250 - 252
  • [46] Study of plasma levels of Aβ1-42, Aβ1-40, and p-tau in Alzheimer disease
    Peng, D
    Cai, X
    Xu, X
    Wang, X
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (04): : 614 - 615
  • [47] Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42/Aβ1-40 ratio - a cross-validation study against amyloid PET
    Pannee, Josef
    Portelius, Erik
    Minthon, Lennart
    Gobom, Johan
    Andreasson, Ulf
    Zetterberg, Henrik
    Hansson, Oskar
    Blennow, Kaj
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 (04) : 651 - 658
  • [48] Mixing Aβ(1-40) and Aβ(1-42) peptides generates unique amyloid fibrils
    Cerofolini, Linda
    Ravera, Enrico
    Bologna, Sara
    Wiglenda, Thomas
    Boeddrich, Annett
    Purfuerst, Bettina
    Benilova, Iryna
    Korsak, Magdalena
    Gallo, Gianluca
    Rizzo, Domenico
    Gonnelli, Leonardo
    Fragai, Marco
    De Strooper, Bart
    Wanker, Erich E.
    Luchinat, Claudio
    CHEMICAL COMMUNICATIONS, 2020, 56 (62) : 8830 - 8833
  • [49] Clinical use and analytical problems in amyloid-beta(1-42) and tau protein in cefalorachidic fluid as markers of Alzheimer's disease
    Kang, Ju-Hee
    Korecka, Magdalena
    Toledo, Jon B.
    Trojanowski, John Q.
    Shaw, Leslie M.
    BIOCHIMICA CLINICA, 2014, 38 (03) : 255 - 267
  • [50] Plasma levels of amyloid beta protein species (A beta 1-40 and A beta 1-42(43)) are elevated in Down's syndrome.
    Tamaoka, A
    Tokuda, T
    Fukushima, T
    Ikeda, S
    Sekijima, Y
    Shoji, S
    Yanagisawa, N
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S39 - S39
12345